BioSpace News Archive

Genetown

bluebird bio to Host Third Quarter 2023 Financial Results Conference Call

bluebird bio, Inc. (Nasdaq: BLUE) announced today that it will host a conference call to discuss third quarter 2023 financial results and business updates on Tuesday, November 7 at 8:00 a.m. ET.

October 24, 2023
·
1 min read
Genetown

DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

DermBiont, a clinical-stage biotechnology company that is advancing targeted topical therapeutics for the treatment of dermatological indications, today announced a $35.2 million Series B financing, including a $27.1 million Series B first close and $8.1 million in converting outstanding notes.

October 24, 2023
·
4 min read
BioCapital

Elpiscience Announces Three Poster Presentations at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

Elpiscience Biopharmaceuticals, Inc. today announced it will have three poster presentations at the SITC 2023 Annual Meeting taking place November 3-5, 2023, in San Diego.

October 24, 2023
·
2 min read
Drug Development

Sparrow Pharmaceuticals Doses First Patient in Phase 2 ACSpire Study of SPI-62 for Autonomous Cortisol Secretion

Sparrow Pharmaceuticals today announced that the first patient has been dosed in the Phase 2 ACSpire study (NCT number: NCT05436639 ) of SPI-62.

October 24, 2023
·
3 min read
Business

Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call

Neuronetics, Inc. today announced that it plans to release third quarter 2023 financial and operating results prior to market open on Tuesday, November 7th, 2023.

October 24, 2023
·
1 min read
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a significant breakthrough in the treatment of non-small cell lung cancer (NSCLC) with resistance to certain targeted therapies.

October 24, 2023
·
5 min read
Biotech Bay

Levita® Magnetics Announces World’s First Commercial Use of MARS Surgical System

Levita Magnetics, whose mission is to help more patients get access to better surgery, announced today the world’s first commercial use of its MARS™ platform.

October 24, 2023
·
3 min read
Business

Varex Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2023 following the close of regular trading on Tuesday, November 14, 2023.

October 24, 2023
·
1 min read
Business

Experienced Business Development Leader Joins Sage Product Development, Inc. in Key Vice President Role

Sage Product Development, Inc., a leading medical device contract product development and early-stage manufacturing firm, is excited to announce the appointment of Laurie Bourgeois as Vice President of Business Development.

October 24, 2023
·
2 min read
Business

Nephron Announces Hiring of Key Executives

Nephron Pharmaceuticals Corporation announced the new hiring of six key executives.

October 24, 2023
·
5 min read